Quarterly report pursuant to Section 13 or 15(d)

INVESTMENTS - Narrative (Details)

v3.22.1
INVESTMENTS - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 01, 2022
EUR (€)
shares
Dec. 21, 2018
EUR (€)
Dec. 31, 2020
USD ($)
Jan. 31, 2019
EUR (€)
Jun. 30, 2022
USD ($)
Jun. 30, 2022
EUR (€)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Sep. 30, 2020
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
€ / shares
Dec. 01, 2020
Nov. 30, 2020
Sep. 30, 2020
EUR (€)
Sep. 30, 2019
USD ($)
shares
Sep. 30, 2019
EUR (€)
shares
Dec. 21, 2018
USD ($)
investor
shares
Dec. 21, 2018
EUR (€)
investor
€ / shares
shares
Summary of Investment Holdings [Line Items]                                    
Investment – Cansativa | $             $ 1,394,000     $ 1,458,000                
Goodwill | $                   $ 0                
Loss from investments | $             64,000 $ 11,000                    
Preferred Shares | Cansativa                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued, price per share (Euro per share) | € / shares                     € 543.31              
Seed Financing Round | Cansativa                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued (in shares) | shares                                 3,096 3,096
Investments, fully diluted pre-money valuation                                   € 8,500,000
Seed Financing Round | Preferred Shares | Cansativa                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued, price per share (Euro per share) | € / shares                                   € 322,970
Cansativa                                    
Summary of Investment Holdings [Line Items]                                    
Percentage of interest held 9.00%                   14.22%              
Gain (loss) on investments | $     $ 211,000                              
Sale of stock, number of shares issued/sold in transaction (in shares) | shares 1,586                                  
Sale of stock, number of shares issued/sold in transaction (in shares) € 2,300,000                                  
Loss from investments | $             $ 64,000 $ 11,000                    
Cansativa | Forecast                                    
Summary of Investment Holdings [Line Items]                                    
Sale of stock, number of shares issued/sold in transaction (in shares)           € 2,300,000                        
Gain (loss) on sale of equity method investments | $         $ 2,055,000                          
Cansativa | Common Stock                                    
Summary of Investment Holdings [Line Items]                                    
Number of shares registered and fully paid-in capital (in shares) | shares                                 26,318 26,318
Cansativa | Seed Financing Round                                    
Summary of Investment Holdings [Line Items]                                    
Investments, net                                   € 7,000,000
Number of investment tranches | investor                                 3 3
Percentage of interest held                                 10.53% 10.53%
Payments to acquire investments   € 3,100   € 996,820                            
Share price (Euro per share) | € / shares                                   € 1.00
Investment – Cansativa                                 $ 1,075,000 € 999,920
Investments, initial amount                                   3,100
Investments, capital reverse payment                                   996,820
Investments, additional                             $ 722,000 € 650,000    
Investments, additional, shares (in shares) | shares                             2,138 2,138    
Investments, consideration transferred, net assets                             16.60% 16.60%    
Net assets                               € 1,233,000    
Goodwill                               € 1,122,000    
Cansativa | Seed Financing Round | Cansativa, Employee Stock Ownership Plan (ESOP)                                    
Summary of Investment Holdings [Line Items]                                    
Percentage of interest held                       15.80% 16.59%          
Cansativa | Seed Financing Round | Preferred Shares                                    
Summary of Investment Holdings [Line Items]                                    
Percentage of interest held                     14.22% 15.80%            
Cansativa | Tranche One                                    
Summary of Investment Holdings [Line Items]                                    
Investments, gross                                   1,000,000
Cansativa | Tranche One | Seed Financing Round                                    
Summary of Investment Holdings [Line Items]                                    
Investments, gross                                 $ 1,075,000 999,920
Cansativa | Tranche Two | Seed Financing Round                                    
Summary of Investment Holdings [Line Items]                                    
Investments, gross                           € 0       3,000,000
Gain (loss) on investments | $                 $ (370,000)                  
Cansativa | Tranche Three | Seed Financing Round                                    
Summary of Investment Holdings [Line Items]                                    
Investments, gross                                   € 3,000,000